
DNA vs ATTO
$DNA vs $ATTO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNA vs ATTO: the quick read
- ·DNA is the larger company by market cap ($787M vs $784M).
- ·DNA has been more active on our scanner (274 vs 86 alerts in 30 days).
- ·ATTO has the smaller float (43.2M vs 62.0M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·DNA draws far more of our scanner's attention, 274 unusual-volume alerts in 30 days against 86, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 0% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: DNA is near the top of its 52-week range while ATTO is near the bottom of its own.
- ·They are pulling apart today: DNA is outperforming the other by roughly 16.8 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNA and ATTO on TheDesperateTrader.
- Is DNA or ATTO the better stock?
- "Better" depends on your goal, and these two are not alike. DNA is the larger company by market cap ($787M vs $784M). DNA has been more active on our scanner (274 vs 86 alerts in 30 days). ATTO has the smaller float (43.2M vs 62.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNA and ATTO?
- The differences that matter: they are similar in size ($787M vs $784M); they trade at very different share prices ($14.98 vs $17.95); DNA sits at 79% of its 52-week range against 15% for ATTO; our scanner flagged DNA 274 times in the last 30 days against 86 for ATTO. Everything above is measured from the latest completed session and SEC filings.
- Which of DNA and ATTO is more active right now?
- Right now DNA is at about 1.2x its normal volume and ATTO is at about 1.0x, so DNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNA or ATTO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNA and ATTO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.